Piramal Phytocare (Delisted) share news and announcements

BSE: 532979

Formerly Piramal Life Sciences

Last traded ₹22.70 on 10 Dec 2019

Delisted on 27 May 2020.

Piramal Phytocare share news and announcements

488 announcements, routine notices left out, newest first. Page 7 of 10.

Nov 2013
- 7 Nov · Management
  Mr. Ankit Sheth resigned as the Company Secretary of the Company effective November 07, 2013.
Oct 2013
- 24 Oct · Board meeting
  Board of Directors of the Company at its Meeting held on October 24, 2013 took on record resignation of Dr. Somesh Sharma who has step down as Director of the Company. The Board of Directors have placed on record their appreciation and gratitude for the invaluable contributions made by Dr. Somesh Sharma during his tenure as member of the Board.
- 24 Oct · Board meeting
  Board of Directors of the Company at its meeting held on October 24, 2013, inter alia, has taken following decision : - Dr. Somesh ....
- 24 Oct · Results
  Standalone financial results for the period ended 30-sep-2013. (opens in a new tab)
- 24 Oct · Results
  Financial Results & a copy of the Limited Review Report for the period ended September 30, 2013. (opens in a new tab)
- 17 Oct · Name and Symbol Change
  Members of the Exchange are hereby informed that the name of Piramal Life Sciences Limited shall be changed to Piramal Phytocare Limited and the trading symbol of the Company be changed from PIRLIFE to PIRPHYTO w.e.f. October 23, 2013.
- 17 Oct · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2013.
Aug 2013
- 5 Aug · Meeting
  The 12th Annual General Meeting (AGM) of the Company was held on July 31, 2013. (opens in a new tab)
Jul 2013
- 31 Jul · Results
  Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013. (opens in a new tab)
- 31 Jul · Results
  Financial Results & a copy of the Limited Review Report for the period ended June 30, 2013. (opens in a new tab)
- 23 Jul · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter ended June 30, 2013. The results shall be subject to limited review.
Jun 2013
- 28 Jun · Information related to Employee Benefit Scheme
  Details of employee benefit scheme involving dealings in secondary market, pursuant to SEBI Circular dated May 13, 2013. (opens in a new tab)
- 3 Jun · Name Change
  Board of Directors of the Company have approved the proposal to change the name of the Company from Piramal Life Sciences Limited to Piramal Phytocare Limited or such other name as may be approved by the Registrar of Companies / other statutory authorities. Until recently, the word "Life Sciences" in the name of the Company appropriately reflected the research and development activity carried out by the Company. Consequent to the demerger of the NCE Research Unit of the Company to Piramal Enterprises Limited, the current business profile of the Company comprises product development and marketing of Herbal products. In order to appropriately reflect the Company's changed business profile in its name, it is proposed that the name of the Company be changed to "Piramal Phytocare Limited". The proposed change in name would be subject to approval of the shareholders and the Central Government.
May 2013
- 31 May · Change of Name of the Company
  Board of Directors of the Company have approved the proposal to change the name of the Company from Piramal Life Sciences Limited to ....
- 8 May · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from July 23, 2013 to July 31, 2013 (both days inclusive) ....
- 8 May · Results
  Standalone Financial Results for the period ended March 31,2013. (opens in a new tab)
- 8 May · Results
  Financial Results for the period ended March 31, 2013. (opens in a new tab)
Apr 2013
- 29 Apr · Board meeting
  To inter-alia consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2013.
Feb 2013
- 15 Feb · Information related to Employee Benefit Scheme
  Details of Employee Benefit Schemes involving dealing in Secondary Market, pursuant to SEBI circular dated January 17, 2013. (opens in a new tab)
- 1 Feb · Results
  Financial Results & a copy of the Limited Review Report for the period ended December 31, 2012. (opens in a new tab)
- 1 Feb · Results
  Standalone Financial Results along with the Limited Review Report for the period ended December 31,2012. (opens in a new tab)
Jan 2013
- 24 Jan · Board meeting
  Inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and nine months ended December 31,2012.
- 10 Jan · Disclosure
  Vide letter dated December 28, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 along with a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 and Regulation 13(3) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. (opens in a new tab)
- 4 Jan · Disclosure
  Propiedades Realties Pvt Ltd has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 4 Jan · Disclosure
  PHL Holdings Pvt Ltd has submitted the disclosure under Regulation 13(4A) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE (opens in a new tab)
- 4 Jan · Disclosure
  PHL Holdings Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 4 Jan · Disclosure
  Propiedades Realties Pvt Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 4 Jan · Disclosure
  Propiedades Realties Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 4 Jan · Disclosure
  Piramal Life Sciences Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 2 Jan · Disclosure
  Vide letter dated January 02, 2013 a Copy of Disclosures under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. (opens in a new tab)
- 2 Jan · Disclosure
  Sri Krishna Trust has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 1 Jan · Disclosure
  Vide letter dated December 31, 2012 a copy of Disclosure under Regulation 13(1), 13(2), 13(2A), 13(3), 13 (4), 13(4A) & 13 (6) of SEBI (Prohibition of Insider Trading) Regulations, 1992. (opens in a new tab)
- 1 Jan · Disclosure
  Vide its letter dated December 31, 2012 a copy of disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
- 1 Jan · Disclosure
  Vide its letter dated December 31, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. (opens in a new tab)
Dec 2012
Nov 2012